Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisation application for DuoCover
- Details
- Category: Bristol-Myers Squibb
![The European Medicines Agency (EMEA) The European Medicines Agency (EMEA)](http://www.worldpharmanews.com/images/stories/logo/emea.gif)
Sanofi Pharma Bristol-Myers Squibb SNC withdraws its marketing authorisation for DuoPlavin
- Details
- Category: Sanofi
![The European Medicines Agency (EMEA) The European Medicines Agency (EMEA)](http://www.worldpharmanews.com/images/stories/logo/emea.gif)
Amgen Posts Medical Education and Foundation Grants and Donations
- Details
- Category: Amgen
![Amgen Amgen](http://www.worldpharmanews.com/images/stories/logo/amgen.gif)
High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
A promising start into 2008 for Nycomed
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
FivePrime and Pfizer Enter Oncology and Diabetes Collaboration
- Details
- Category: Business
Five Prime Therapeutics, Inc. and Pfizer Inc. (NYSE:PFE) today announced the initiation of a worldwide collaborative research and license agreement. The collaboration will focus on the discovery of antibody targets and novel therapeutic protein products to treat certain areas of cancer and diabetes.
First pre-pandemic vaccine approved to help protect against pandemic influenza
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
More Pharma News ...
- Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent
- Pfiser's List of Grants and Charitable Contributions
- Lapatinib (Tykerb/Tyverb) to be investigated in landmark early breast cancer trial
- Boehringer Ingelheim announces commitment to progressing science with the Bouquet Studies
- Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis
- International study to evaluate efficacy and safety in treating a leading cause of blindness
- Highlight Potential of Novel Oral Compound for Gaucher Disease